|
[guanidine-14C]Debrisoquine |
|
|
|
Ethanol solution. |
|
|
1.85-2.29 GBq/mmol, 50-62
mCi/mmol. |
|
|
1.85 MBq/ml, 50 µCi/ml. |
|
| |
|
|
|
|
|
|
Freeze-dried solid. |
|
|
~ 74 TBq/mmol, ~ 2000 Ci/mmol. |
|
|
|
|
| |
|
Redivue™ deoxyadenosine 5'-[a-35S]-thiotriphosphate,
triethylammonium salt |
|
|
|
Redivue™ stabilized and colored aqueous solution containing 5 mM
2-mercaptoethanol and 20 mM DTT. |
|
|
General purpose. |
|
|
~ 22 TBq/mmol, ~ 600 Ci/mmol. |
|
|
370 MBq/ml, 10 mCi/ml. |
|
| |
|
|
|
|
Deoxyadenosine 5'-[a-35S]thiotriphosphate, triethylammonium salt
|
|
|
|
Stabilized aqueous solution containing 20 mM DTT. |
|
|
~ 22 TBq/mmol, ~ 600 Ci/mmol. |
|
|
370 MBq/ml, 10 mCi/ml. |
|
|
QC-tested using typical DNA-labeling protocol. |
|
| |
|
|
|
|
Redivue™ deoxyadenosine 5'-[a-35S]-thiotriphosphate,
triethylammonium salt |
|
|
|
Redivue™ stabilized and colored aqueous solution containing 5 mM
2-mercaptoethanol and 20 mM DTT. |
|
|
General purpose. |
|
|
~ 22 TBq/mmol, ~ 600 Ci/mmol. |
|
|
370 MBq/ml, 10 mCi/ml. |
|
| |
|
|
|
|
Deoxyadenosine 5'-[a-35S]thiotriphosphate, triethylammonium salt
|
|
|
|
Stabilized aqueous solution containing 20 mM DTT. |
|
|
~ 22 TBq/mmol, ~ 600 Ci/mmol. |
|
|
370 MBq/ml, 10 mCi/ml. |
|
|
QC-tested using typical DNA-labeling protocol. |
|
| |
|
|
|
|
Deoxyadenosine 5'-[a-35S]thiotriphosphate, triethylammonium salt
(in situ grade) |
|
|
|
Stabilized aqueous solution containing no DTT. |
|
|
> 37 TBq/mmol, > 1000 Ci/mmol. |
|
|
370 MBq/ml, 10 mCi/ml. |
|
|
QC-tested using typical DNA-labeling protocol. |
|
| |
|
|
|
|
Deoxy[2,8-3H]adenosine 5'-triphosphate, ammonium salt |
|
|
|
Ethanol:water (1:1) solution. |
|
|
185-925 GBq/mmol; 5-25
Ci/mmol. |
|
|
37 MBq/ml, 1 mCi/ml. |
|
| |
|
|
|
|
Redivue™ deoxyadenosine 5'-[a-32P] triphosphate,
triethylammonium salt |
|
|
|
Redivue™ stabilized and colored aqueous solution containing 5 mM
2-mercaptoethanol. |
|
|
~ 220 TBq/mmol, ~ 6000 Ci/mmol. |
|
|
370 MBq/ml, 10 mCi/ml. |
|
|
QC-tested using typical DNA-labeling protocol. |
|
| |
|
|
|
|
Deoxyadenosine 5'-[a-32P]triphosphate, triethylammonium salt |
|
|
|
Stabilized aqueous solution containing 5 mM 2-mercaptoethanol. |
|
|
~ 220 TBq/mmol, ~ 6000 Ci/mmol. |
|
|
370 MBq/ml, 10 mCi/ml. |
|
|
QC-tested using typical DNA-labeling protocol. |
|
| |
|
|
|
|
Redivue™ deoxyadenosine 5'-[a-32P] triphosphate,
triethylammonium salt |
|
|
|
Redivue™ stabilized and colored aqueous solution containing 5 mM
2-mercaptoethanol. |
|
|
~ 110 TBq/mmol, ~ 3000 Ci/mmol. |
|
|
370 MBq/ml, 10 mCi/ml. |
|
|
QC-tested using typical DNA-labeling protocol. |
|
| |
|
|
|
|
Deoxyadenosine 5'-[a-32P]triphosphate, triethylammonium salt |
|
|
|
Stabilized aqueous solution containing 5 mM 2-mercaptoethanol. |
|
|
~ 110 TBq/mmol, ~ 3000 Ci/mmol. |
|
|
370 MBq/ml, 10 mCi/ml. |
|
|
QC-tested using typical DNA-labeling protocol. |
|
| |
|
|
|
|
Redivue™ deoxyadenosine 5'-[a-32P] triphosphate,
triethylammonium salt |
|
|
|
Redivue™ stabilized and colored aqueous solution containing 5 mM
2-mercaptoethanol. |
|
|
~ 30 TBq/mmol, ~ 800 Ci/mmol. |
|
|
370 MBq/ml, 10 mCi/ml. |
|
|
QC-tested using typical DNA-labeling protocol. |
|
| |
|
|
|
|
Deoxyadenosine 5'-[a-32P]triphosphate, triethylammonium salt |
|
|
|
Stabilized aqueous solution containing 5 mM 2-mercaptoethanol. |
|
|
~ 220 TBq/mmol, ~ 6000 Ci/mmol. |
|
|
370 MBq/ml, 10 mCi/ml. |
|
|
QC-tested using typical DNA-labeling protocol. |
|
| |
|
|
|
|
Redivue™ deoxyadenosine 5'-[a-32P]- triphosphate,
triethylammonium salt |
|
|
|
Redivue™ stabilized and colored aqueous solution containing 5 mM
2-mercaptoethanol. |
|
|
~ 15 TBq/mmol, ~ 400 Ci/mmol. |
|
|
370 MBq/ml, 10 mCi/ml. |
|
| |
|
|
|
|
Redivue™ deoxyadenosine 5'-[a-33P]- triphosphate,
triethylammonium salt |
|
|
|
Redivue™ stabilized and colored aqueous solution containing 5 mM
2-mercaptoethanol. |
|
|
~ 92.5 TBq/mmol, ~ 2500 Ci/mmol. |
|
|
370 MBq/ml, 10 mCi/ml. |
|
|
QC-tested using typical DNA-labeling protocol. |
|
| |
|
|
|
|
Deoxyadenosine 5'-[a-33P]triphosphate, triethylammonium salt |
|
|
|
Stabilized aqueous solution containing 5 mM 2-mercaptoethanol. |
|
|
~ 220 TBq/mmol, ~ 6000 Ci/mmol. |
|
|
370 MBq/ml, 10 mCi/ml. |
|
|
QC-tested using typical DNA-labeling protocol. |
|
| |
|
|
|
|
|
|
Aqueous solution containing 2% ethanol, sterilized. |
|
|
General purpose. |
|
|
333-925 GBq/mmol, 9-25
Ci/mmol. |
|
|
37 MBq/ml, 1 mCi/ml. |
|
| |
|
|
|
|
Redivue™ deoxycytidine 5'-[a-35S]- thiotriphosphate,
triethylammonium salt |
|
|
|
Redivue™ stabilized and colored aqueous solution containing 5 mM
2-mercaptoethanol and 20 mM DTT. |
|
|
General purpose. |
|
|
> 37 TBq/mmol, > 1000 Ci/mmol. |
|
|
370 MBq/ml, 10 mCi/ml. |
|
| |
|
|
|
|
Deoxycytidine 5'-[a-35S]thiotriphosphate, triethylammonium salt
|
|
|
|
Stabilized aqueous solution containing 20 mM DTT. |
|
|
General purpose. |
|
|
> 37 TBq/mmol, > 1000 Ci/mmol. |
|
|
370 MBq/ml, 10 mCi/ml. |
|
| |
|
|
|
|
Deoxy[1',2',5-3H]cytidine 5'-triphosphate, triethylammonium salt
|
|
|
|
Ethanol:water (1:1) solution. |
|
|
1.8-3.1 TBq/mmol, 50-85
Ci/mmol. |
|
|
37 MBq/ml, 1 mCi/ml. |
|
| |
|
|
|
|
Deoxy[5-3H]cytidine 5'-triphosphate, triethylammonium salt |
|
|
|
Ethanol:water (1:1) solution. |
|
|
General purpose. |
|
|
0.55-1.1 TBq/mmol, 15-30 Ci/mmol. |
|
|
37 MBq/ml, 1 mCi/ml. |
|
| |
|
|
|
|
Redivue™ deoxycytidine 5'-[a-32P] triphosphate, triethylammonium
salt |
|
|
|
Redivue™ stabilized and colored aqueous solution containing 5 mM
2-mercaptoethanol. |
|
|
~ 220 TBq/mmol, ~ 6000 Ci/mmol. |
|
|
370 MBq/ml, 10 mCi/ml. |
|
|
QC-tested using typical DNA-labeling protocol. |
|
| |
|
|
|
|
Deoxycytidine 5'-[a-32P]triphosphate, triethylammonium salt |
|
|
|
Stabilized aqueous solution containing 5 mM 2-mercaptoethanol. |
|
|
~ 15 TBq/mmol, ~ 400 Ci/mmol. |
|
|
370 MBq/ml, 10 mCi/ml. |
|
|
QC-tested using typical DNA-labeling protocol. |
|
| |
|
|
|
|
Redivue™ deoxycytidine 5'-[a-32P]- triphosphate,
triethylammonium salt |
|
|
|
Redivue™ stabilized and colored aqueous solution containing 5 mM
2-mercaptoethanol. |
|
|
~ 110 TBq/mmol, ~ 3000 Ci/mmol. |
|
|
370 MBq/ml, 10 mCi/ml. |
|
|
QC-tested using typical DNA-labeling protocol. |
|
| |
|
|
|
|
Redivue Tip™ deoxycytidine 5'-[a-32P] triphosphate,
triethylammonium salt |
|
|
|
Solution free format preloaded into pipette tips. |
|
|
~ 110 TBq/mmol, ~ 3000 Ci/mmol. |
|
|
Each pack contains 5 tips. |
|
| |
|
|
|
|
Deoxycytidine 5'-[a-32P]triphosphate, triethylammonium salt |
|
|
|
Stabilized aqueous solution containing 5 mM 2-mercaptoethanol. |
|
|
~ 110 TBq/mmol, ~ 3000 Ci/mmol. |
|
|
370 MBq/ml, 10 mCi/ml. |
|
|
QC-tested using typical DNA-labeling protocol. |
|
| |
|
|
|
|
Redivue™ deoxycytidine 5'-[a-32P]- triphosphate,
triethylammonium salt |
|
|
|
Redivue™ stabilized and colored aqueous solution containing 5 mM
2-mercaptoethanol. |
|
|
~ 30 TBq/mmol, ~ 800 Ci/mmol. |
|
|
370 MBq/ml, 10 mCi/ml. |
|
|
QC-tested using typical DNA-labeling protocol. |
|
| |
|
|
|
|
Deoxycytidine 5'-[a-32P]triphosphate, triethylammonium salt |
|
|
|
Stabilized aqueous solution containing 5 mM 2-mercaptoethanol. |
|
|
~ 30 TBq/mmol, ~ 800 Ci/mmol. |
|
|
370 MBq/ml, 10 mCi/ml. |
|
|
QC-tested using typical DNA-labeling protocol. |
|
| |
|
|
|
|
Redivue™ deoxycytidine 5'-[a-32P]- triphosphate,
triethylammonium salt |
|
|
|
Redivue™ stabilized and colored aqueous solution containing 5 mM
2-mercaptoethanol. |
|
|
~ 15 TBq/mmol, ~ 400 Ci/mmol. |
|
|
370 MBq/ml, 10 mCi/ml. |
|
|
QC-tested using typical DNA-labeling protocol. |
|
| |
|
|
|
|
Deoxycytidine 5'-[a-32P]triphosphate, triethylammonium salt |
|
|
|
Stabilized aqueous solution containing 5 mM 2-mercaptoethanol. |
|
|
~ 15 TBq/mmol, ~ 400 Ci/mmol. |
|
|
370 MBq/ml, 10 mCi/ml. |
|
|
QC-tested using typical DNA-labeling protocol. |
|
| |
|
|
|
|
Redivue™ deoxycytidine 5'-[a-33P]- triphosphate,
triethylammonium salt |
|
|
|
Redivue™ stabilized and colored aqueous solution containing 5 mM
2-mercaptoethanol. |
|
|
~ 92.5 TBq/mmol, ~ 2500 Ci/mmol. |
|
|
370 MBq/ml, 10 mCi/ml. |
|
|
QC-tested using typical DNA-labeling protocol. |
|
| |
|
|
|
|
Deoxycytidine 5'-[a-33P]-triphosphate, triethylammonium salt |
|
|
|
Stabilized aqueous solution containing 5 mM 2-mercaptoethanol. |
|
|
~ 92.5 TBq/mmol, ~ 2500 Ci/mmol. |
|
|
370 MBq/ml, 10 mCi/ml. |
|
|
QC-tested using typical DNA-labeling protocol. |
|
| |
|
|
|
|
|
|
Aqueous solution, sterilized. |
|
|
8.5-12.2 GBq/mmol, 230-330
mCi/mmol. |
|
|
7.4 MBq/ml, 200 µCi/ml. |
|
| |
|
|
|
|
|
|
Aqueous solution, sterilized. |
|
|
8.5-12.2 GBq/mmol, 230-330
mCi/mmol. |
|
|
7.4 MBq/ml, 200 µCi/ml. |
|
| |
|
|
|
|
|
|
Aqueous solution, sterilized. |
|
|
1.85-2.29 GBq/mmol, 50-62
mCi/mmol. |
|
|
7.4 MBq/ml, 200 µCi/ml. |
|
| |
|
|
|
|
|
|
Aqueous solution, sterilized. |
|
|
1.85-2.29 GBq/mmol, 50-62
mCi/mmol. |
|
|
7.4 MBq/ml, 200 µCi/ml. |
|
| |
|
|
|
|
|
|
Aqueous solution, sterilized. |
|
|
185-740 GBq/mmol, 5-20
Ci/mmol. |
|
|
37 MBq/ml, 1 mCi/ml. |
|
| |
|
|
|
|
2-Deoxy-d-[2,6-3H]glucose |
|
|
|
Ethanol:water (1:1) solution. |
|
|
0.92-2.03 TBq/mmol, 25-55
Ci/mmol. |
|
|
37 MBq/ml, 1 mCi/ml. |
|
| |
|
|
|
|
Deoxy[1',2'-3H]guanosine 5'-triphosphate, ammonium salt |
|
|
|
Ethanol:water (1:1) solution. |
|
|
General purpose. |
|
|
0.9-1.85 TBq/mmol, 25-50
Ci/mmol. |
|
|
37 MBq/ml, 1 mCi/ml. |
|
| |
|
|
|
|
Deoxy[8-3H]guanosine 5'-triphosphate, ammonium salt |
|
|
|
Ethanol:water (1:1) solution. |
|
|
185-740 GBq/mmol, 5-20
Ci/mmol. |
|
|
37 MBq/ml, 1 mCi/ml. |
|
| |
|
|
|
|
Redivue™ deoxyguanosine 5'-[a-32P]- triphosphate,
triethylammonium salt |
|
|
|
Redivue™ stabilized and colored aqueous solution containing 5 mM
2-mercaptoethanol. |
|
|
~ 110 TBq/mmol, ~ 3000 Ci/mmol. |
|
|
370 MBq/ml, 10 mCi/ml. |
|
|
QC-tested using typical DNA-labeling protocol. |
|
| |
|
|
|
|
Deoxyguanosine 5'-[a-32P]triphosphate, triethylammonium salt |
|
|
|
Stabilized aqueous solution containing 5 mM 2-mercaptoethanol. |
|
|
~ 110 TBq/mmol, ~ 3000 Ci/mmol. |
|
|
370 MBq/ml, 10 mCi/ml. |
|
|
QC-tested using typical DNA-labeling protocol. |
|
| |
|
|
|
|
Redivue™ deoxyguanosine 5'-[a-32P]- triphosphate,
triethylammonium salt |
|
|
|
Redivue™ stabilized and colored aqueous solution containing 5 mM
2-mercaptoethanol. |
|
|
~ 30 TBq/mmol, ~ 800 Ci/mmol. |
|
|
370 MBq/ml, 10 mCi/ml. |
|
|
QC-tested using typical DNA-labeling protocol. |
|
| |
|
|
|
|
Deoxyguanosine 5'-[a-32P]triphosphate, triethylammonium salt |
|
|
|
Stabilized aqueous solution containing 5 mM 2-mercaptoethanol. |
|
|
~ 30 TBq/mmol, ~ 800 Ci/mmol. |
|
|
370 MBq/ml, 10 mCi/ml. |
|
|
QC-tested using typical DNA-labeling protocol. |
|
| |
|
|
|
|
Deoxyguanosine 5'-[a-32P]triphosphate, triethylammonium salt |
|
|
|
Stabilized aqueous solution containing 5 mM 2-mercaptoethanol. |
|
|
~ 110 TBq/mmol, ~ 3000 Ci/mmol. |
|
|
370 MBq/ml, 10 mCi/ml. |
|
|
QC-tested using typical DNA-labeling protocol. |
|
| |
|
|
|
|
Redivue™ deoxythymidine 5'-[a-32P]- triphosphate,
triethylammonium salt |
|
|
|
Redivue™ stabilized and colored aqueous solution containing 5 mM
2-mercaptoethanol. |
|
|
~ 110 TBq/mmol, ~ 3000 Ci/mmol. |
|
|
370 MBq/ml, 10 mCi/ml. |
|
|
QC-tested using typical DNA-labeling protocol. |
|
| |
|
|
|
|
Deoxythymidine 5'-[a-32P]triphosphate, triethylammonium salt |
|
|
|
Stabilized aqueous solution containing 5 mM 2-mercaptoethanol. |
|
|
~ 110 TBq/mmol, ~ 3000 Ci/mmol. |
|
|
370 MBq/ml, 10 mCi/ml. |
|
|
QC-tested using typical DNA-labeling protocol. |
|
| |
|
|
|
|
Redivue™ deoxythymidine 5'-[a-32P]- triphosphate,
triethylammonium salt |
|
|
|
Redivue™ stabilized and colored aqueous solution containing 5 mM
2-mercaptoethanol. |
|
|
~ 30 TBq/mmol, ~ 800 Ci/mmol. |
|
|
370 MBq/ml, 10 mCi/ml. |
|
|
QC-tested using typical DNA-labeling protocol. |
|
| |
|
|
|
|
Deoxythymidine 5'-[a-32P]triphosphate, triethylammonium salt |
|
|
|
Stabilized aqueous solution containing 5 mM 2-mercaptoethanol. |
|
|
~ 30 TBq/mmol, ~ 800 Ci/mmol. |
|
|
370 MBq/ml, 10 mCi/ml. |
|
|
QC-tested using typical DNA-labeling protocol. |
|
| |
|
|
|
|
Deoxythymidine 5'-[a-32P]triphosphate, triethylammonium salt |
|
|
|
Stabilized aqueous solution containing 5 mM 2-mercaptoethanol. |
|
|
~ 15 TBq/mmol, ~ 400 Ci/mmol. |
|
|
370 MBq/ml, 10 mCi/ml. |
|
|
QC-tested using typical DNA-labeling protocol. |
|
| |
|
|
|
|
Deoxy[5-3H]uridine 5'-triphosphate, ammonium salt |
|
|
|
Ethanol:water (1:1) solution. |
|
|
0.185-1.11 TBq/mmol, 5-30
Ci/mmol. |
|
|
37 MBq/ml, 1 mCi/ml. |
|
| |
|
|
|
|
(-)-[N-methyl-3H]Desmethoxyverapamil ((-)-[3H]D-888) |
|
|
|
Ethanol solution containing 0.01 M HCl. |
|
|
2.2-3.1 TBq/mmol, 60-85
Ci/mmol. |
|
|
37 MBq/ml, 1 mCi/ml. |
|
| |
|
|
|
|
[1,2,4,6,7-3H]Dexamethasone |
|
|
|
Ethanol solution. |
|
|
2.6-4.1 TBq/mmol, 70-110
Ci/mmol. |
|
|
37 MBq/ml, 1 mCi/ml. |
|
| |
|
|
|
|
|
|
Ethanol solution. |
|
|
1.3-2.2 TBq/mmol, 35-60
Ci/mmol. |
|
|
37 MBq/ml, 1 mCi/ml. |
|
| |
|
|
|
|
|
|
Solid (Mr ~
70 000). |
|
|
3.7-18.5 GBq/g, 100-500
mCi/g. |
|
| |
|
|
|
|
Diabetes-associated peptide, rat, 125I-labelled with Bolton &
Hunter reagent |
|
|
|
Freeze-dried solid. |
|
|
~ 74 TBq/mmol, ~ 2000 Ci/mmol. |
|
|
Made to order, please inquire for availability. |
|
| |
|
|
|
|
|
|
Ethanol solution. |
|
|
1.85-2.29 GBq/mmol, 50-62
mCi/mmol. |
|
|
3.7 MBq/ml, 100 µCi/ml. |
|
| |
|
|
|
|
Dideoxyadenosine 5'-[a-32P]triphosphate, triethylammonium salt |
|
|
|
Stabilized aqueous solution containing 5 mM 2-mercaptoethanol. |
|
|
~ 185 TBq/mmol, ~ 5000 Ci/mmol. |
|
|
370 MBq/ml, 10 mCi/ml. |
|
| |
|
|
|
|
Dideoxyadenosine 5'-[a-32P]triphosphate, triethylammonium salt |
|
|
|
Stabilized aqueous solution containing 5 mM 2-mercaptoethanol. |
|
|
~ 110 TBq/mmol, ~ 3000 Ci/mmol. |
|
|
370 MBq/ml, 10 mCi/ml. |
|
| |
|
|
|
|
|
|
Liquid in sealed ampoule. |
|
|
1.85-2.29 GBq/mmol, 50-62 mCi/mmol. |
|
|
Available 2 weeks from date of order. |
|
|
When stored as recommended, has been shown to be usable for at least 1
month. |
|
| |
|
|
|
|
l-[4,6-propyl-3H]Dihydroalprenolol |
|
|
|
Ethanol:water (9:1) solution. |
|
|
2.6-4.1 TBq/mmol, 70-110
Ci/mmol. |
|
|
37 MBq/ml, 1 mCi/ml. |
|
| |
|
|
|
|
l-[propyl-2,3-3H]Dihydroalprenolol |
|
|
|
Ethanol solution. |
|
|
1.11-2.22 TBq/mmol, 30-60
Ci/mmol. |
|
|
37 MBq/ml, 1 mCi/ml. |
|
|
Made to order, please inquire for availability. |
|
| |
|
|
|
|
13,14-Dihydro-15-keto- [5,6,8,9,11,12,14(n)-3H]prostaglandin F2a
|
|
|
|
Ethanol solution, sealed under nitrogen. |
|
|
4.8-7.4 TBq/mmol, 130-200
Ci/mmol. |
|
|
3.7 MBq/ml, 100 µCi/ml. |
|
| |
|
|
|
|
5a-Dihydro[1,2,4,5,6,7-3H]testosterone |
|
|
|
Toluene:ethanol (9:1) solution. |
|
|
3.7-5.5 TBq/mmol, 100-150
Ci/mmol. |
|
|
37 MBq/ml, 1 mCi/ml. |
|
| |
|
|
|
|
5a-Dihydro[1a,2a(n)-3H]testosterone |
|
|
|
Toluene:ethanol (9:1) solution. |
|
|
1.48-2.59 TBq/mmol, 40-70
Ci/mmol. |
|
|
37 MBq/ml, 1 mCi/ml. |
|
|
Made to order, please inquire for availability. |
|
| |
|
|
|
|
1a,25-Dihydroxy[23,24(n)-3H]cholecalciferol |
|
|
|
Toluene:ethanol (1:1) solution. |
|
|
2.96-4.44 TBq/mmol, 80-120
Ci/mmol. |
|
|
370 kBq/ml, 10 µCi/ml. |
|
| |
|
|
|
|
1a,25-Dihydroxy[26,27-methyl-3H]- cholecalciferol |
|
|
|
Toluene:ethanol (1:1) solution. |
|
|
4.8-6.7 TBq/mmol, 130-180
Ci/mmol. |
|
|
370 kBq/ml, 10 µCi/ml. |
|
| |
|
|
|
|
24R,25-Dihydroxy[26,27-methyl-3H]- cholecalciferol |
|
|
|
Toluene:ethanol (1:1) solution. |
|
|
4.8-6.7 TBq/mmol, 130-180
Ci/mmol. |
|
|
185 kBq/ml, 5 µCi/ml. |
|
| |
|
|
|
|
l-3,4-Dihydroxyphenyl[3-14C]alanine |
|
|
|
Aqueous solution containing 2% ethanol, sterilized. |
|
|
1.85-2.29 GBq/mmol, 50-62 mCi/mmol. |
|
|
1.85 MBq/ml, 50 µCi/ml. |
|
| |
|
|
|
|
|
|
Liquid in sealed ampoule. |
|
|
1.85-2.29 GBq/mmol, 50-62 mCi/mmol. |
|
|
Available 4 weeks from date of order. |
|
| |
|
|
|
|
1,3-Dinitro[U-14C]benzene |
|
|
|
Solid in screw capped vial. |
|
|
3.7-4.59 GBq/mmol, 100-124 mCi/mmol. |
|
|
Available 4 weeks from date of order. |
|
| |
|
|
|
|
Dipotassium hydrogen[32P]orthophosphate |
|
|
|
Aqueous solution. |
|
|
~ 7.4 GBq/mmol, ~ 200 mCi/mmol. |
|
|
37 MBq/ml, 1 mCi/ml. |
|
| |
|
|
|
|
|
|
Ethanol solution. |
|
|
0.9-1.85 TBq/mmol, 25-50
Ci/mmol. |
|
|
37 MBq/ml, 1 mCi/ml. |
|
|
Kd = 1.2 × 10-10
M (rat); 1 nM toward mu and kappa opioid receptors in rabbit and guinea
pig respectively; 2.5 nM, 0.66 nM, and 0.75 nM for human
d, µ and
k, respectively. |
|
|
Made to order, please inquire for availability. |
|
| |
|
|
|
|
|
|
Buffered aqueous solution, sterilized. |
|
|
0.55-1.85 MBq/mg, 15-50
µCi/mg. |
|
| |
|
|
|
|
|
|
0.02 M Acetic acid:ethanol (1:1) solution, sterilized. |
|
|
148-888 GBq/mmol, 4-24
Ci/mmol. |
|
|
37 MBq/ml, 1 mCi/ml. |
|
| |
|
|
|
|
|
|
Acetic acid:ethanol (1:1) solution. |
|
|
1.5-2.2 TBq/mmol, 40-60
Ci/mmol. |
|
|
37 MBq/ml, 1 mCi/ml. |
|
| |
|
|
|
|
[14-14C]Doxorubicin hydrochloride ([14C]Adriamycin) |
|
|
|
Freeze-dried solid. |
|
|
1.85-2.29 GBq/mmol, 50-62
mCi/mmol. |
|